Medication Abortion Health Risks Late-Term Abortion Fetal Viability Medical Emergencies Legal Framework Legal Regulations Legal Restrictions Medical Ethics Abortion Restrictions Pregnancy Abortion Access Dilation and Evacuation Mental Health Medical Abortion Medication Abortions Survivors of Abortion Legal Exceptions Illegal Abortions Historical Abortion Practices Self-managed Abortion Medical Care Access Healthcare Access Health Policies Foetal Viability Viability Standards Medical Treatments Risks and Complications Medical Guidelines Legal Implications of Abortion Impact on Women Legal Abortion Access to Abortion Abortion Regulations Medical Professionals Abortion Bans Legal Battles Mifepristone Women's Health Risks Emergency Medical Care Abortion Pills Dilation and Curettage Viability Legal Status Chemical Abortion Late-Term Abortions Medical Regulations Trimesters Late-term Abortion Reproductive Freedoms Second-Trimester Abortion Pregnancy Complications Fetal Development Maternal Health Patient Rights Health Care Access Safety Standards Medical Necessity Health Risks of Abortion Medical Risks Health Policy Medical Complications
The ruling applies Prop. 139’s standard, immediately restoring access curtailed by pre‑viability limits.
